These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35485994)

  • 21. Randomized clinical trial: Effects of Aloe barbadensis Mill. extract on symptoms, fecal microbiota and fecal metabolite profiles in patients with irritable bowel syndrome.
    Ahluwalia B; Magnusson MK; Böhn L; Störsrud S; Larsson F; Savolainen O; Ross A; Simrén M; Öhman L
    Neurogastroenterol Motil; 2020 Aug; 32(8):e13860. PubMed ID: 32314514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Carroll IM; Ringel-Kulka T; Siddle JP; Ringel Y
    Neurogastroenterol Motil; 2012 Jun; 24(6):521-30, e248. PubMed ID: 22339879
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical response to fecal microbiota transplantation in patients with diarrhea-predominant irritable bowel syndrome is associated with normalization of fecal microbiota composition and short-chain fatty acid levels.
    Mazzawi T; Hausken T; Hov JR; Valeur J; Sangnes DA; El-Salhy M; Gilja OH; Hatlebakk JG; Lied GA
    Scand J Gastroenterol; 2019 Jun; 54(6):690-699. PubMed ID: 31190584
    [No Abstract]   [Full Text] [Related]  

  • 24. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome.
    Róka R; Rosztóczy A; Leveque M; Izbéki F; Nagy F; Molnár T; Lonovics J; Garcia-Villar R; Fioramonti J; Wittmann T; Bueno L
    Clin Gastroenterol Hepatol; 2007 May; 5(5):550-5. PubMed ID: 17336590
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FODMAP diet modulates visceral nociception by lipopolysaccharide-mediated intestinal inflammation and barrier dysfunction.
    Zhou SY; Gillilland M; Wu X; Leelasinjaroen P; Zhang G; Zhou H; Ye B; Lu Y; Owyang C
    J Clin Invest; 2018 Jan; 128(1):267-280. PubMed ID: 29202473
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
    Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
    Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome.
    Yang M; Zhang L; Hong G; Li Y; Li G; Qian W; Xiong H; Bai T; Song J; Hou X
    J Gastroenterol Hepatol; 2020 May; 35(5):795-805. PubMed ID: 31674052
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome.
    Shin A; Camilleri M; Vijayvargiya P; Busciglio I; Burton D; Ryks M; Rhoten D; Lueke A; Saenger A; Girtman A; Zinsmeister AR
    Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1270-1275.e1. PubMed ID: 23639599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The networks of human gut microbe-metabolite associations are different between health and irritable bowel syndrome.
    Shankar V; Homer D; Rigsbee L; Khamis HJ; Michail S; Raymer M; Reo NV; Paliy O
    ISME J; 2015 Aug; 9(8):1899-903. PubMed ID: 25635640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome.
    Carroll IM; Chang YH; Park J; Sartor RB; Ringel Y
    Gut Pathog; 2010 Dec; 2(1):19. PubMed ID: 21143915
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Systematic Review: Fecal Bacterial Profile in Patients with Irritable Bowel Syndrome Analyzed with the GA-Map Dysbiosis Test Based on the 16S rRNA Gene of Bacterial Species or Groups.
    Teige ES; Sortvik U; Lied GA
    Clin Exp Gastroenterol; 2024; 17():109-120. PubMed ID: 38646157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mucosal-Associated Microbiota Other Than Luminal Microbiota Has a Close Relationship With Diarrhea-Predominant Irritable Bowel Syndrome.
    Yang M; Hong G; Jin Y; Li Y; Li G; Hou X
    Front Cell Infect Microbiol; 2020; 10():515614. PubMed ID: 33224895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex-based differences in fecal short-chain fatty acid and gut microbiota in irritable bowel syndrome patients.
    Sun QH; Liu ZJ; Zhang L; Wei H; Song LJ; Zhu SW; He MB; Duan LP
    J Dig Dis; 2021 May; 22(5):246-255. PubMed ID: 33822477
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome.
    Compare D; Rocco A; Coccoli P; Angrisani D; Sgamato C; Iovine B; Salvatore U; Nardone G
    BMC Gastroenterol; 2017 Apr; 17(1):53. PubMed ID: 28410580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome.
    Jalanka-Tuovinen J; Salojärvi J; Salonen A; Immonen O; Garsed K; Kelly FM; Zaitoun A; Palva A; Spiller RC; de Vos WM
    Gut; 2014 Nov; 63(11):1737-45. PubMed ID: 24310267
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transplantation of fecal microbiota from patients with irritable bowel syndrome alters gut function and behavior in recipient mice.
    De Palma G; Lynch MD; Lu J; Dang VT; Deng Y; Jury J; Umeh G; Miranda PM; Pigrau Pastor M; Sidani S; Pinto-Sanchez MI; Philip V; McLean PG; Hagelsieb MG; Surette MG; Bergonzelli GE; Verdu EF; Britz-McKibbin P; Neufeld JD; Collins SM; Bercik P
    Sci Transl Med; 2017 Mar; 9(379):. PubMed ID: 28251905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes.
    Hughes PA; Harrington AM; Castro J; Liebregts T; Adam B; Grasby DJ; Isaacs NJ; Maldeniya L; Martin CM; Persson J; Andrews JM; Holtmann G; Blackshaw LA; Brierley SM
    Gut; 2013 Oct; 62(10):1456-65. PubMed ID: 22767422
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased serum levels of lipopolysaccharide and antiflagellin antibodies in patients with diarrhea-predominant irritable bowel syndrome.
    Dlugosz A; Nowak P; D'Amato M; Mohammadian Kermani G; Nyström J; Abdurahman S; Lindberg G
    Neurogastroenterol Motil; 2015 Dec; 27(12):1747-54. PubMed ID: 26387872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of Gut Microbiota and Metabolites Signature in Patients With Irritable Bowel Syndrome.
    Zhu S; Liu S; Li H; Zhang Z; Zhang Q; Chen L; Zhao Y; Chen Y; Gu J; Min L; Zhang S
    Front Cell Infect Microbiol; 2019; 9():346. PubMed ID: 31681624
    [No Abstract]   [Full Text] [Related]  

  • 40. The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome.
    Iribarren C; Magnusson MK; Vigsnæs LK; Aziz I; Amundsen ID; Šuligoj T; Juge N; Patel P; Sapnara M; Johnsen L; Sørensen N; Sundin J; Törnblom H; Simrén M; Öhman L
    Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.